Market News How it works Learn FAQ
| GPUS 0.1689 34.05% | XXII 0.1977 -8.34% | SHFS 0.1324 -61.39% | NVD 4.19 0.96% | LUCD 0.411 25.42% | SPCX 147.49 1.89% | T 20.93 -7.96% | SOXL 83.56 1.77% | NU 15.16 2.92% | NOK 8.14 3.30% | EWZ 42.59 1.77% | NVDA 210.96 -0.59% | RIME 0.106 -12.90% | INTC 86.96 1.72% | TSLG 4.87 -1.62% | AAL 12.11 -3.89% | BBD 4.07 3.04% | STLA 4.06 -4.81% | SOXS 52.46 -1.85% | RWM 14.55 0.34% | HYG 77.05 -0.06% | MYND 0.24 47.42% | BITO 10.83 -0.28% | SPDN 8.54 0.47% | YFOR 0.2236 -1.58% | RBNE 0.19 -2.56% | TQQQ 66.29 -0.20% | VZ 44.66 -1.19% | TSLL 9.76 -1.21% | SPTI 27.63 -0.11% | YMAT 2.05 6.77% | CRWV 54.235 -2.46% | INFY 12.35 -6.58% | RIG 6.41 5.43% | F 11.6 -2.85% | SQQQ 39.68 0.20% | AIOK 12.02 182.82% | ONDS 6.2 2.99% | AAPL 347.725 -0.14% | LABT 0.31 -36.67% | CDE 13.45 -3.10% | PCG 12.63 -2.70% | GRAB 2.79 -2.11% | SOFI 14.615 -1.05% | XLE 69.33 2.60% | IREN 24.905 -2.37% | QID 14.55 0.14% | RKT 11.73 -0.09% | WULF 11.32 0.00% | BE 193.3 -11.24%
OSOraSure Technologies, Inc. logo

OraSure Technologies, Inc. (OSUR)

NASDAQ Global Select · Currency in USD
$4.13 ▲ +0.33 (+8.68%)
At close: Oct 23, 4:00 PM ET. Market closed.
$4.13 ▲ +0.00 (+0.00%)
After hours: Oct 23, 7:30 PM ET

Summary

Previous Close
$3.80
Open
$3.94
Day's Range
$3.89 – $4.18
52 Week Range
$2.08 – $4.58
Volume
1,158,220
Avg. Volume
514,998
Market Cap
$284.84M
Beta (5Y Monthly)
1.02
PE Ratio (TTM)
--
EPS (TTM)
-$0.71
Earnings Date
Nov 4, 2026
Forward Dividend & Yield
--
Ex-Dividend Date
Jan 8, 1998
1y Target Est
$7.00

Profile: OraSure Technologies, Inc.

Sector
Healthcare
Industry
Medical - Instruments & Supplies
Full-time employees
500
CEO
Carrie Eglinton Manner

OraSure Technologies, Inc. and its affiliates are a global leader in the development, production, and commercialization of advanced oral fluid diagnostic solutions and specialized specimen collection tools, serving markets across the United States, Europe, and other international regions. The company operates through two primary divisions: Diagnostics and Molecular Solutions. Its diverse Diagnostics portfolio features a range of crucial offerings, such as the InteliSwab rapid tests for COVID-19 (including professional and prescription versions).

Earnings

Next report: Wed, Nov 4, 2026
EPS estimate -$0.18 · Revenue est. $31.00M
DateEst.Actual
Aug 5, 2026-$0.27$0.09Beat
May 6, 2026-$0.23-$0.32Miss
Feb 25, 2026-$0.17-$0.27Miss
Nov 5, 2025-$0.16-$0.19Miss
Aug 5, 2025-$0.19-$0.26Miss
May 7, 2025-$0.15-$0.18Miss

Analyst view

Consensus price target
$7.00 ▲ +69.5%
Range $7.00 – $7.00
Rating: Hold
Buy 31% · Hold 69% · Sell 0%

Get free alerts on OSUR and big market moves

Free special alerts by text & email on new investment opportunities, buyouts and the stocks moving most, in plain English.
Get free stock alerts →
Data: Financial Modeling Prep. For information only, not investment advice.